ViroPharma Incorporated

(NASDAQ:VPHM)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 179,691 179,691 179,691 51,524
Cash At End Of Period 612,808 496,534 324,211 179,691
Net Change In Cash And Cash Equivalents 433,117 316,843 144,520 128,167
Effect Of Exchange Rate Changes -176 -10 -77 5
Net Income Or Loss 68,594 41,520 17,450 95,353
Cash From Operating Activities
Depreciation Expenses 6,108 4,494 2,006 6,924
Amortization Expenses — — — —
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes 12,044 11,270 4,872 11,464
Operating Gains Or Losses — — — —
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables -814 -6,409 -3,285 -10,042
Increase Or Decrease In Inventories -438 28 -469 57
Increase Or Decrease In Prepaid Expenses 1,884 -2,129 -3,513 -111
Increase Or Decrease In Other Current Assets 1,884 -2,129 -3,513 -111
Increase Or Decrease In Payables — — — —
Increase Or Decrease In Other Current Liabilities 2,480 -208 21 -726
Increase Or Decrease In Other Working Capital -3,540 -2,195 -4,806 10,603
Other Non Cash Items -2,533 -519 -114 1,120
Net Cash From Continuing Operations 7,079 4,475 2,261 8,225
Net Cash From Discontinued Operations 90,864 50,327 14,423 122,867
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments — — — —
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -2,360 -622 -1,091 -14,816
Acquisitions — — — —
Purchase Of Long Term Investments — — — —
Purchase Of Short Term Investments — — — -789,707
Other Investing Changes Net -7,000 -2,078 — —
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities 340,861 266,302 130,047 -216,176
Cash From Financing Activities
Issuance Of Debt 306 224 127 712
Issuance Of Capital Stock — — — —
Repayment Of Debt — — — -23,250
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends 1,262 — — 2,184
Net Other Financing Charges 1,262 — — 2,184
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities 1,568 224 127 221,471